VolitionRX Ltd (AMEX: VNRX) established initial surge of 1.64% at $0.45, as the Stock market unbolted on Thursday, before settling in for the price of $0.44 at the close. Taking a more long-term approach, VNRX posted a 52-week range of $0.40-$0.94.
It was noted that the giant of the Healthcare sector posted annual sales growth of 5.38% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 5.38%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 38.71%. This publicly-traded company’s shares outstanding now amounts to $103.98 million, simultaneously with a float of $79.03 million. The organization now has a market capitalization sitting at $53.28 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6236, while the 200-day Moving Average is $0.6022.
VolitionRX Ltd (VNRX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the VolitionRX Ltd industry. VolitionRX Ltd’s current insider ownership accounts for 26.54%, in contrast to 22.32% institutional ownership. According to the most recent insider trade that took place on Oct 14 ’25, this organization’s President and CEO bought 110,000 shares at the rate of 0.51, making the entire transaction reach 56,100 in total value, affecting insider ownership by 2,534,847. Preceding that transaction, on Oct 14 ’25, Company’s Director bought 96,153 for 0.51, making the whole transaction’s value amount to 49,038. This particular insider is now the holder of 1,062,967 in total.
VolitionRX Ltd (VNRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
VolitionRX Ltd’s EPS increase for this current 12-month fiscal period is 38.71% and is forecasted to reach -0.07 in the upcoming year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Let’s observe the current performance indicators for VolitionRX Ltd (VNRX). It’s Quick Ratio in the last reported quarter now stands at 0.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 40.36.
In the same vein, VNRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.24, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.07 at the market close of one year from today.
Technical Analysis of VolitionRX Ltd (VNRX)
Now, what If we examine the latest scores posted by [VolitionRX Ltd, VNRX]. During the last 5-days, its volume was better the volume of 0.25 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 7.07% While, its Average True Range was 24.14.
Raw Stochastic average of VolitionRX Ltd (VNRX) in the period of the previous 100 days is set at 3.37%, which indicates a major fall in contrast to 5.55% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0469 that was lower than 0.0567 volatility it exhibited in the past 100-days period.
